Phase 1 dose escalation study of BQS481 in advanced solid tumours

• Research type

  Research Study

• Full title

  A phase IA open label, dose escalation study of BQS481 administered intravenously to adult patients with advanced solid tumours

• IRAS ID

  6983

• Contact name

  Anne Thomas

• Contact email

  at107@le.ac.uk

• Sponsor organisation

  Novartis Pharma Services

• Eudract number

  2008-003551-69

• ISRCTN Number

  N/A

• Research summary

  Research Summary not published at request of researcher

• REC name

  West Midlands - Coventry & Warwickshire Research Ethics Committee

• REC reference

  09/H1211/7

• Date of REC Opinion

  5 Mar 2009

• REC opinion

  Further Information Favourable Opinion